Jennifer Kayden Lee - EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Head of North America
Issuer Symbol
RYTM on Nasdaq
All Insider Reports
All Insider Reports

Jennifer Kayden Lee - trading volume in the past year for RHYTHM PHARMACEUTICALS, INC.

Holdings reported by Jennifer Kayden Lee for RHYTHM PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 19,233 $2,096,204 $108.99 01 Feb 2026 Direct
Restricted Stock Units 27,487 $944,130 $57.22 01 Feb 2026 Direct Common Stock
Stock Options (Right to Buy) 55,000 14 Feb 2025 Direct Common Stock
Stock Option (Right to Buy) 21,601 09 Feb 2025 Direct Common Stock

Transactions reported by Jennifer Kayden Lee for RHYTHM PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.